IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $229,000 | -56.6% | 11,975 | -44.1% | 0.14% | -58.6% |
Q3 2021 | $528,000 | -4.2% | 21,430 | +1.3% | 0.33% | -2.4% |
Q2 2021 | $551,000 | +66.5% | 21,159 | +102.5% | 0.33% | +42.1% |
Q1 2021 | $331,000 | +28.3% | 10,450 | +88.3% | 0.24% | -3.7% |
Q4 2020 | $258,000 | +15.7% | 5,550 | -18.1% | 0.24% | +5.2% |
Q3 2020 | $223,000 | -8.6% | 6,775 | -23.7% | 0.23% | -6.5% |
Q2 2020 | $244,000 | +14.6% | 8,875 | +25.0% | 0.25% | -2.7% |
Q1 2020 | $213,000 | – | 7,100 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |